Neuroscience
Generalized Anxiety Disorder
100%
Placebo
100%
Functional Magnetic Resonance Imaging
66%
Cholinergic
50%
Defensive Behavior
50%
Behavior (Neuroscience)
50%
Personality Traits
50%
Treatment-Resistant Depression
50%
Benzodiazepine
50%
Enzalutamide
50%
Meta-Analysis
50%
Lorazepam
33%
Anxiety Disorder
33%
N-Methyl-D-Aspartic Acid
33%
Androgen Receptor
18%
Amygdala
16%
Alpha-7 Nicotinic Receptor
16%
Face
16%
Drug Therapy
16%
Glutamate Decarboxylase
16%
Cholinergic Transmission
16%
Central Nervous System
12%
Magnetic Resonance Imaging
12%
Blood Brain Barrier
12%
Ketamine
8%
Mood Stabilizer
8%
Depressive Disorder
8%
Occipital Lobe
6%
Cognitive Function
6%
Gray Matter
6%
Crossover Study
6%
Dorsolateral Prefrontal Cortex
6%
Omeprazole
6%
Psychology
Generalized Anxiety Disorder
100%
Functional Magnetic Resonance Imaging
66%
Meta-Analysis
50%
Systematic Review
50%
Personality Trait
50%
Child Development
50%
State Anxiety
50%
Benzodiazepine
50%
Anxiety Disorder
33%
Psychological Treatment
16%
Placebo Effect
16%
Psychological Effect
16%
Neurotransmission
16%
Drug Therapy
16%
Amygdala
16%
Pharmacology, Toxicology and Pharmaceutical Science
Treatment Resistant Depression
50%
Clinical Trial
50%
N Methyl Dextro Aspartic Acid
33%
Generalized Anxiety Disorder
16%
Placebo
16%
Mood Stabilizer
8%
Depressive Disorder
8%
Ketamine
8%
